Drug Profile
Research programme: antiviral therapeutics - Integrated Biotherapeutics
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Integrated BioTherapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Viral-infections in USA
- 15 Sep 2009 Early research in Viral infections in USA (unspecified route)
- 15 Sep 2009 Antimicrobial data from an In vitro trial in Viral infections presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2009)